Dow Down 0.92% Nasdaq Down 0.83%

Regulus Therapeutics Inc. (RGLS)

-NasdaqGM
13.75 6.98(103.10%) Oct 22, 4:00PM EDT
|Pre-Market : 14.25 Up 0.50 (3.64%) 7:49AM EDT - Nasdaq Real Time Price
Prev Close:6.77
Open:14.47
Bid:13.75 x 1000
Ask:13.98 x 100
1y Target Est:17.20
Beta:0.684
Earnings Date:Nov 11 - Nov 17 (Est.)
Day's Range:11.13 - 15.38
52wk Range:5.40 - 15.38
Volume:20,316,750
Avg Vol (3m):374,520
Market Cap:596.64M
P/E (ttm):N/A
EPS (ttm):-0.69
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for RGLS

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):21.07
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.01
Quarterly EPS Est (Sep-14) :-0.21
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regulus Therapeutics Inc., a biopharmaceutical company, focuses on the discovery and development of drugs that target microRNAs for the treatment of various diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback